Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Latest News Headlines for Cell Therapeutics Inc
Cell Therapeutics (CTIC) Mkt On Close Buy Imbalance: Shrs N/A
Wednesday 12/02/2009 3:55 PM ET - T
Cell Therapeutics (CTIC) Mkt On Close Buy Imbalance: Shrs 88026
Wednesday 12/02/2009 3:52 PM ET - T
give me 2 seconds ill send links of the yahoo chart. look at the year 2000 and 1999 let me know what you see give me a min.
Sent an email to the President of the company hopefully he will reply back
I think your right but this will be a small run the phase 3 conference will be a huge part also then it gets approved it'll be huge like 15 to 20 dollars a share!! marry Christmas to us!! When they came out with Trisenox it went from 77 dollars a share to 2940 at peak after 8 months look at company's history then match to chart you'll see!!
what you mean?
Thisis a bit weird looks like the home page is down when you try to bring it up.
Parse error: parse error, unexpected T_STRING in /home/content/a/j/e/ajengel/html/index.php on line 60
I wonder if you can access the sight any where else to put in orders.
They need to get the product going thats wha they need to do now.lol Man this company is kind of retarted.
thank you for pointing that out thats what I said
Here's what we do know they had this debt and the company they owed it to had to have a reason to settle for less right? So maybe they know something that we all don't like when and how hard this product is going to hit? Like you said when? i think its coming soon it would be commercial has been paid for and the sight as well now they just have to finish what they started!
Any body fore see a huge jump any time soon with this news?
First off read my last post its .13 on the dollar so yes maybe there expecting now a huge spike. Another point would say that if the company settled for this to pay off debt then maybe there is something huge comeing so good point on this I think something is comeing! Hopeing.lol Any other inputs?
Zevotek, Inc. (Pink Sheets:ZVTK) (Frankfurt: T5V1.F), a worldwide direct marketer and distributor of innovative personal and home care items, today announced that on November 25, 2009 it entered into a settlement agreement with its former CEO pursuant to which it extinguished an outstanding liability of approximately $490,000 in unpaid compensation and severance in exchange for the issuance of 30,000,000 shares of its common stock. Based upon the November 25, 2009 closing price, the stock payment had a value of approximately $63,000. In addition, under the terms of the Settlement Agreement, Zevotek obtained a full release from its former CEO for any and all past or future claims against it or its subsidiaries.
"The settlement eliminated the single largest liability on Zevotek's books, one that represented about 33% of Zevotek's current liabilities as reported on the September 30, 2009 balance sheet," said Adam Engel, CEO of Zevotek. "Zevotek improved its balance sheet and eliminated a potential distraction from our focus on launching the Ionic Bulb." Commenting on the settlement terms, he added, "We settled by paying with shares instead of cash. We settled this claim for about 13 cents on the dollar. In addition, the settlement allows us to avoid any further costs, burdens, or distractions, and uncertainties of litigation relating to claims by our former CEO and allows us to focus our efforts on generating revenues for the Company."
So we should start to see some green coming in?
who knows man they might have an action date to turn on the link and all it shows is December instead of the exact day. Hopefully will see we know the infomercial airs this month and online activates so this month will be interesting thats for sure. Will see pray to god every day for it! Hopefully we can see .05 out of first months sales!
I don't have a clue dude.
I dunno it was on my account through Scottrade. So when will it go back up?
Latest News Headlines for Cell Therapeutics Inc
Cell Therapeutics (CTIC) Mkt On Close Sell Imbalance: Shrs 164350
34 minutes ago - T
Cell Therapeutics (CTIC) Mkt On Close Sell Imbalance: Shrs 378950
37 minutes ago - T
Could this be the reason?
LOL- Actually on the site on the infomercial it says buy one now on it for 19.95 and get one free.
Question now is when?
So what you mean that the report of sale hasn't come out yet or that its fake?
New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents
Monday 11/30/2009 1:30 AM ET - Pr Newswire
Related Companies
Symbol Last %Chg
CTIC 1.11 0.00%
As of 1:00 PM ET 11/27/09
Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that its new class of platinum-based anti-tumor compounds, termed bis-platinates, demonstrated a stronger anti-tumor potency and activity compared to currently available platinum-based compounds as well as the ability to overcome cisplatin-resistance in cancer cell lines. The results were presented in a paper titled "Novel Bis-platinum Complexes Endowed with an Improved Pharmacological Profile," by Laura Gatti et al. that was published in the online edition of the journal Molecular Pharmaceutics. Platinum-based compounds, such as cisplatin and oxaliplatin, are the cornerstone in the treatment of testicular, ovarian, colorectal, lung and other cancers but their effectiveness is limited by the relatively low therapeutic ratio, the ratio of the maximally tolerated dose of the drug to the effective dose, and the frequent occurrence of drug resistance leading to cancer recurrence. The novel bis-platinum compounds represent a completely new class of platinum-based drugs called bisplatinates.
The bis-platinum based compounds, unlike the currently approved platinum-based compounds, contain two platinum atoms and work by binding to and damaging both strands of DNA making it much more difficult for cancer cells to repair the damage. The research demonstrated through cancer cell assays and animal tumor models that the bis-platinum complexes exhibited greater cytotoxic potency and anti-tumor effect compared to cisplatin and oxaliplatin. There was more than a 200-fold increase in percent accumulation in tumor cells of the bisplatinum compounds compared to cisplatin and oxaliplatin. The bisplatinates were substantially more active against human tumors grown in an immunodeficient preclinical model than the standard palatinate compounds, oxaliplatin, carboplatin and cisplatin. Furthermore, the bis-platinum compounds demonstrated the ability to overcome tumor resistance to cisplatin mediated by DNA mismatch repair defects. The complexes showed marked anti-tumor efficacy in platinum refractory tumors, with significant activity in terms of tumor growth inhibition and tumor growth delay.
"Platinum-based compounds are cornerstone agents in the treatment of very common cancers such as cancers of the lung, colon, and ovary and are also widely used in other gynecological tumors, testicular cancers, and cancers of the esophagus, head and neck. They are increasingly being used for salvage therapy in lymphoma. However, resistance to palatinate compounds is common. The current results are encouraging as they demonstrate that the bisplatinates are not only more effective in human tumor models than the current agents, but also capable of overcoming some forms of palatinate resistance," said Jack Singer, M.D., Chief Medical Officer of CTI.
About Cell Therapeutics, Inc.
Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit www.CellTherapeutics.com.
Sign up for email alerts and get RSS feeds at our Web site, http://www.CellTherapeutics.com/investors_alert
This press release includes forward-looking statements that involve a number of risks and uncertainties, the outcome of which could materially and/or adversely affect actual future results and the trading price of the securities of CTI. Specifically, the risks and uncertainties that could affect the development of pixantrone include risks associated with preclinical and clinical developments in the biopharmaceutical industry in general, and with bis-platinum based compounds in particular, including, without limitation, the potential failure of bis-platinums to prove effective in inhibiting or delaying tumor growth or to overcome cisplatin resistance or to be safe or effective in animals or humans, that CTI does not enter clinical trials for the bis-platinates in 2010, CTI's ability to continue to raise capital as needed to fund its operations, competitive factors, technological developments, costs of developing, producing and selling pixantrone, and the risk factors listed or described from time to time in CTI's filings with the Securities and Exchange Commission including, without limitation, CTI's most recent filings on Forms 10-K, 10-Q and 8-K. Except as may be required by law, CTI does not intend to update or alter its forward-looking statements whether as a result of new information, future events, or otherwise.
You do have time this int the main run by far we should see a nice medium one over the next few days wait till the FDA approves the drug!
I don't think that it is going to get any lower than .002 because the bid hasn't been below .0018 in a long time not id buy some now if you can then hold! It should be any day now that the icon is able to work to be able to purchase this product. The news will come out of commercial.
Here's How to Buy Gold for $32.60 an Ounce!
Fellow Investor:
Gold at $1,100 an ounce is putting cold, hard cash in lots of people's pockets.
A grandfather's "ugly" gold cuff links that no one wears... a hand-me-down gold charm bracelet... an out-of-style solid gold pin... thanks to $1,100-an-ounce gold, people everywhere are trading long-forgotten gold jewelry for cash.
So too, the long-forgotten gold in some of America's abandoned gold mines is suddenly attracting a rush of attention.
Historic, 19th-century gold mines, worked by hand until the easy pickings were gone, are being rediscovered. Skyrocketing gold prices and modern recovery techniques make it hugely profitable now to revisit some of the west's once-most-productive gold mines, one of which could still have...
1.5 to 3 Million Ounces of Gold!
Buy Ironwood Gold Corp (IROG: OTCBB) Now
While it's Still About $0.75. Every Share You Buy
Gets You .023 Ounces of In-The-Ground Gold!
Gold Target: $2300 with
US Hyperinflation
Gold is likely to make a new inflation-adjusted high before its current bull move ends. That's the word from Frank Holmes the man behind the Morningstar 5-star rated U.S. Global Investors Gold and Precious Metals Fund, which is up 33% in the past year. The journey to new highs will come with bumps along the road. Holmes predicts several 10% price swings in the near future. But, he firmly believes negative interest rates combined with massive deficits is a recipe for gold to shine. What's his price target? Holmes predicts gold can easily reach $2300 - the inflation-adjusted high it reached in the early 1980s.
Here's the short version of what this is all about:
As the price of gold began to soar toward $1,100 an ounce and many analysts began predicting $2,000 an ounce gold within the next 2 years, it dawned on a few savvy investors that – like a gold charm bracelet that might have originally cost $350 and is now worth $4,500 – the long-forgotten remnant gold in abandoned gold mines is now worth countless billions!
Suddenly there was a new “21st century gold rush” to discover which historic projects represent the most recoverable gold for the least amount of effort.
And here's the thing that excites me as an investor: like the gold merchant who snaps up that long-forgotten gold bracelet at way below its current value, an opportunistic startup company by the name of Ironwood Gold Corp. (IROG: OTCBB) has just signed a deal for the 22 unpatented claims (approximately 363 acres) and the three patented claims (another 59 acres) that define the old Cobalt Canyon project, at a price that's reminiscent of gold before the 1970s!
Two of the mining industry's most experienced geologists have recently prepared a report on the historic Cobalt Canyon project in southeastern Nevada.
You'll find details on their credentials, how they conducted their analysis and all the data to support their findings when you click on the link below.
But let me cut to the chase. . .here's the meat of their Technical Report On The Cobalt Canyon Project, It states (and this is a direct quote from their independent, certified report):
“. . .the resource could approach 3 million ounces of gold. . .the potential for discovering 1 million ounces of gold on the project appears to be quite good.”
You do the math, using a conservative number, 1.5 million ounces of gold at (call it $1,100 an ounce) works out to $1.65 billion (that's billion with a "B") dollars worth of gold! Now, divide the number of ounces (1.5 million) by the number of shares of Ironwood stock (65.2 million) and you come up with 0.023 ounces of gold for each share of Ironwood stock. At $0.75 a share. . .
You're Paying $32.60 for an Ounce of Gold!
Buy 43.47 shares of Ironwood Gold Corp (IROG: OTCBB) at about 75-cents each and you own an ounce of in-the-ground gold! At, call it 75-cents a share, that works out to a cost of just $32.60 per ounce!
The Best Gold Play Now: Ironwood Gold Corp
(IROG: OTCBB) While It's Still Under $0.75!
More and more nervous investors are putting money in gold to protect their nest eggs against an uncertain stock market and the very real possibility of runaway inflation—caused by a plunging U.S. dollar. For safety alone, gold should be part of everyone's financial strategy.
But, you can do a lot better than the gold bugs who are loading up exclusively on bullion and gold coins. As gold moves toward $2,000 an ounce in the next two to three years, as it almost certainly will, you could double money parked in gold bullion. But, even if the price of gold remains steady at around $1,100 an ounce, you still could double. . .triple. . .quadruple. . .and then redouble your money again with this exploration-stage start-up company, Ironwood Gold Corp (IROG: OTCBB).
If the geologist's estimate of up to 3 million ounces of gold is accurate, using a price of $1,100 an ounce for gold, that would translate to . . .
$50.61 Worth of Gold for Each 75-Cent
Share of Ironwood Gold Corp. Stock!
I'm urging you to pounce on this gold stock now while you can still get it around 75-cents, before the gold bugs on Wall Street push its price through the ceiling. They will when they discover what's going on!
Who am I and why should you pay attention to what I've written?
My name is Jarret Wollstein. I'm editor of the Intelligent Investor Report, and I have a 30- year history of successful predictions and investment recommendations. In fact in my Intelligent Investor Report. . .
In 2008, a horrible year for most investors, my average stock pick was up
by 24.7% – winners and losers included!
That’s one of the best records of any stock newsletter anywhere. In 2008 – two one of the worst years in memory, some of my stock picks included:
• 160% gain in just 5 months on Alpha Natural Resources (ANR, NYSE),
• 153% gain in 12 months on Fording Coal (FDG, NYSE)
• 120% gain in 18 months on Precsions Cast Parts (PCP, NYSE)
• 114% gain in 16 months on HDFC Bank (HDB, NYSE)
• 108% gain in 18 months on ABB Ltd. (ABB, NYSE)
And again in 2009 we’ve had many big winners, including Jayhawk Energy (JYWK) up 215% in 30 days . . . Freeport McMoran (FCX, NYSE) up 32.27% . . . Goldcorp (GG, NYSE) up 34.90% . . . Natco Group (NTG, NYSE) up 36.06% . . and Trend Technology (TRET, OTC), recently up 375% in less than one month (that’s not a misprint).
I'm also a financial editor for NewsMax.com, with over 1.5 million monthly readers, and the author of over 40 books and Special Reports, including three national best sellers on investing, terrorism and politics. I tell you all of that not to impress you but to make it clear that when I strongly recommend a stock, the chances of it doing well are excellent, so you can invest in confidence in Ironwood Gold (IROG: OTCBB), which I believe it could be my next big winner!
But don't wait too long to invest. Buy shares now at under $1.00, sell half when it gets to $2.00 and then hold the rest for big, long-term gains. I wouldn't be surprised to see this stock trading as high as $5.00 within 12 to 18 months
So next week we should see some more green maybe close in the 1.20 range?
so its supposed to air and be able to by in early December?
you hit the nail right on the brain.lol
what you mean? So your on our side right that it'll go up once revenue comes out and agree its a very short term stock?
is that good or bad?
that would make huge sense with navartis they might purchase the drug as soon as approval for like 10 billion dollars so his stock might just hit like HGSI all at once in a 3 day period.
yeah it didn't work for me either what was on it?
Is that good?
IROG - .78(1), .80(1) X .82(1), .83(2), .85(1), ...
how about we just wait for news on sales before we draw any conclusions
Wow December 1st I don't remember reading that any where? Where did you hear that from?
question is when are they going to come out with some we all no it will go up when they do and gives the media reports for analysis. Is it supposed to air in December or when?
so you don't think it'll do to well? I have friend in the air force thats a doctor and he said nothing out right now can match it and the one drug thats out is crap the fatality rate is still way to high. If you read our analysis on our drug it will do much better in almost every aspect. He even said I picked a kick *** stock becuase there's really nothing on the market for Non-h Lymphoma. After these Reuters are done bashing it will go up but the question is how high with all the shares in this thing?
whats going on with this is building up maybe or will it hit 2.23 again then fall?
any one know when there going to drill or take samples?